Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials
Résumé
In the Introduction, references 23 and 26 were inadvertently omitted in two sentences, and have been added as follows: ‘The Antibody Mediated Prevention (AMP) trials were the first human efficacy studies of infused bnAbs for HIV-1 prevention (HVTN 704/HPTN 085 and HVTN 703/HPTN 081) 23 . The efficacy of a CD4-binding site bnAb, VRC01, was tested in men, women and transgender individuals who were vulnerable to HIV-1 in the Americas, sub-Saharan Africa and Europe 24–26 .’
Citer ce document
Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)
Accès au document
Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter
Voir l'article sur le site de la revueLicence et provenance
Licence : CC BY
Notice moissonnée depuis OpenAlex le 27/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →